Table 1. Demographic Data of Human Subjects.
| Number of patients, n | 423 |
| (Male/Female, n) | (281/142) |
| Age, y | 45±9 |
| Male gender,% | 66±47 |
| Body mass index, kg/m2 | 22.9±3.1 |
| Waist circumference, cm | 83±9 |
| Systolic blood pressure, mmHg | 117±16 |
| Diastolic blood pressure, mmHg | 74±11 |
| Fasting plasma glucose, mg/dL | 95 [90–101] |
| Hemoglobin A1c,% | 5.19±0.29 |
| Immunoreactive insulin, mU/L | 5.0 [4.0–8.0] |
| HOMA-IR | 1.3 [0.8–1.8] |
| Triglycerides, mg/dL | 96 [66–138] |
| HDL-C, mg/dL | 69±18 |
| Total cholesterol, mg/dL | 209±32 |
| LDL-C, mg/dL | 126±31 |
| Non-HDL-C, mg/dL | 139±36 |
| hsCRP, µg/mL | 0.15 [0.10–0.30] |
| Adiponectin, µg/mL | 7.7 [5.7–10.9] |
| VEGF-A, pg/mL | 278 [163–434] |
| VEGF-C, pg/mL | 6135±1409 |
Data are expressed as the mean ± SD, median [25–75 percentile], or number of patients. HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Non-HDL-C: non-high-density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; hsCRP: high-sensitivity C-reactive protein; VEGF-A: vascular endothelial growth factor-A, VEGF-C: vascular endothelial growth factor-C.